RATINGS CHANGES
 
American International  ( AIG - Get Report) was downgraded from hold to sell, Deutsche Bank said. The stock has a $61 price target. The loss of Peter Hancock is a negative.
 
Amrep (AXR - Get Report) was downgraded to sell at TheStreet Ratings. You can view the full analysis from the report here: AXR.
 
Boeing  ( BA - Get Report) was downgraded from overweight to equal-weight, Morgan Stanley said. The stock has a $190 price target. This was a valuation call, as the stock is up 15% year-to-date.
 
Bioverativ  ( BIVV) was downgraded from buy to neutral, Goldman Sachs said. It has a $55 price target. The company is facing increased competition.
 
Blueprint Medicines  ( BPMC - Get Report) was upgraded from neutral to buy, Goldman Sachs said. It has a $52 price target. The company has strong pipeline momentum.
 
Boardwalk Pipeline Partners ( BWP) was upgraded to buy at TheStreet Ratings.You can view the full analysis from the report here: BWP.
 
Rockwell Collins  ( COL) was upgraded to overweight, Morgan Stanley said. It has a $121 price target. The BEAV acquisition could add as much as 30% to earnings.
 
Gartner ( IT - Get Report) was upgraded to top pick, Goldman Sachs said. It has a $124 price target. The CEB acquisition can drive growth over the next several quarters.
 
Johnson Controls  ( JCI - Get Report) was downgraded from buy to neutral, Goldman Sachs said. It has a $44 price target. Analysts see a limited downside to synergy targets.
 
The New York Times ( NYT - Get Report) was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: NYT

This article was written by a staff member of TheStreet.